Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Press Release Apr 08 2021

· Issued by Zydus Lifesciences Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-apr-08-2021-4

Cadila Healthcare Limited has informed the Exchange regarding a press release dated April 08, 2021, titled "Zydus Cadila announces USFDA approval for First Generic for Ibrutinib Capsules, 70 mg and gets eligibility for 180-day exclusivity".

View Attachment

6ix hasn’t read this filing yet.

Zydus Lifesciences Limited on 6ix

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases